In development: Guidance, quality standards and advice
Showing 301 to 303 of 303
Title | Type | Expected publication date |
---|---|---|
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008] | Technology appraisal guidance | TBC |
Zolbetuximab with chemotherapy for untreated claudin 18.2-positive HER2 negative unresectable advanced gastric or gastro-oesophageal junction adenocarcinoma [ID5123] | Technology appraisal guidance | TBC |
Zuranolone for treating severe postnatal depression ID6431 | Technology appraisal guidance | TBC |